| Literature DB >> 30397529 |
A A Kubanov1, A V Runina1, A V Chestkov1, A V Kudryavtseva2, Y A Pekov3, I O Korvigo3, D G Deryabin1.
Abstract
The whole-genome sequencing data of three N. gonorrhoeae strains isolated in the Russian Federation in 2015 are presented. According to the NG-MAST protocol, these strains are related to the globally spread ST 1407 genogroup. The analysis of their resistomes showed the absence of ermA/B/C/F genes and the presence of wild-type alleles of rpsE, rrs, rrl, rplD, rplV, macAB, and mefA genes, and these patterns explain the susceptibility of the sequenced strains to aminocyclitols (spectinomycin) and macrolides (azithromycin). Conjugative resistance determinants (blaTEM, tetM) were absent in the genomes, and the penC/ pilQ, parE, and norM alleles were shown to be wild-type, whereas single or multiple nucleotide substitutions were identified in the genes encoding targets for β-lactams (ponA, penA), tetracyclines (rpsJ), and fluoroquinolones (gyrA, parC). The additional mutations were found in porB gene and the promoter of mtrR gene, which nonspecifically reduced the susceptibility to antimicrobials due to the membrane permeability decrease and efflux pump overexpression. The diversity of mutations observed in the analyzed genomes prompted a revision of the phylogenetic relationships between the strains by comparing more than 790 groups of housekeeping genes. A high homology between the N. gonorrhoeae ST 1407 and N. gonorrhoeae ST 12556 genomes was confirmed; the latter had probably diverged from a common ancestor as a result of single mutation events. On the other hand, N. gonorrhoeae ST 12450 was an example of phenotypic convergence which appeared in the emergence of new drug resistance determinants that partially coincide with those of the ST 1407 genogroup.Entities:
Keywords: Neisseria gonorrhoeae; genetic determinants of antimicrobial drug resistance; phylogenetic analysis; whole genome sequencing
Year: 2018 PMID: 30397529 PMCID: PMC6209400
Source DB: PubMed Journal: Acta Naturae ISSN: 2075-8251 Impact factor: 1.845
Parameters of susceptibility of the analyzed N. gonorrhoeae strains to antimicrobials and their interpretation according to the Methodology Guidelines MUK 4.2.1890–04*
|
Antimicrobial (zones of | MIC, µg/ml | ||
|---|---|---|---|
| 20/15/004 | 41/15/003 | 19/15/005 | |
|
Benzylpenicillin | 0.5 (MS) | 2 (R) | 1 (MS) |
|
Ceftriaxone | 0.015 (S) | 0.03 (S) | 0.015 (S) |
|
Tetracycline | 2 (R) | 4 (R) | 2 (R) |
|
Spectinomycin | 32 (S) | 32 (S) | 16 (S) |
|
Azithromycin** | 0.25 (S) | 0.5 (MS) | 0.25 (S) |
|
Ciprofloxacin (S ≤ 0.06; | 16 (R) | 8 (R) | 16 (R) |
*Methodology Guidelines MUK 4.2.1890–04. Determining Microorganism Susceptibility to Antibacterial Medications: Recommended Practices. Moscow: Federal Center of State Sanitary and Epidemiological Surveillance, Ministry of Health of the Russian Federation, 2004. P. 91.
**As the Methodology Guidelines MUK 4.2.1890–04 contains no criteria for azithromycin susceptibility, the evaluation was carried out using the criteria of the European Committee for Antimicrobial Susceptibility Testing (www.eucast.org)
Overall characteristics of the genomes of the analyzed N. gonorrhoeae strains
| Characteristics | Strains | ||
|---|---|---|---|
| 20/15/004 | 41/15/003 | 19/15/005 | |
| Genome size, bp | 2271213 | 2236575 | 2223815 |
| G+C content, % | 52.6 | 52.5 | 52.7 |
| Number of protein-coding genes | 2448 | 2297 | 2293 |
| Number of protein-coding genes with known function | 1332 | 1266 | 1281 |
| Number of the 16S-23S-5S rRNA genes | 4 | 4 | 4 |
| Number of tRNA genes | 49 | 49 | 47 |
| Number of tmRNA genes | 1 | 1 | 1 |
| Number of “genomic islands” along the bacterial chromosome | 12 | 22 | 17 |
| Plasmid size, bp | 4556 | 5233 | 5266 |
| Plasmid coverage depth to chromosome coverage depth | 18.4 | 12.3 | 33.6 |
Genetic determinants of antimicrobial resistance in N. gonorrhoeae
| Genes (proteins) | Resistance to | Genes and nucleotide polymorphisms (amino acid substitutions) | ||
|---|---|---|---|---|
| 20/15/004 | 41/15/003 | 19/15/005 | ||
| Enzymes responsible for inactivation of antibiotics or modification of their targets | ||||
| blaTEM (β-lactamase) | β-lactams | - | - | - |
| ermA/B/C/F (rRNA methylases) | macrolides | - | - | - |
| Proteins targeting antibiotics | ||||
| ponA (PBP1) | β-lactams | L421P | L421P | L421P |
| penA (PBP2) | β-lactams |
I312M |
I312M | F504L |
| tetM | tetracyclines | - | - | - |
| rpsJ (S10) | tetracyclines | V57M | V57M | V57M |
| rpsE (S5) | spectinomycin | wt | wt | wt |
| rrs (16S RNA) | spectinomycin | wt | wt | wt |
| rrl (23S RNA) | macrolides | wt | wt | wt |
| rplD (L4) | macrolides | wt | wt | wt |
| rplV (L22) | macrolides | wt | wt | wt |
| gyrA | fluoroquinolones |
S91F |
S91F |
S91F |
| parC | fluoroquinolones |
S87R |
S87R | wt |
| parE | fluoroquinolones | wt | wt | wt |
| Transport proteins delivering antibiotics into the cell | ||||
| penB /porB (PorB1b) |
β-lactams | G120K A121N | G120K A121N | G120D |
| penC/pilQ | β-lactams | wt | wt | wt |
| Enzymatic antibiotic efflux systems | ||||
| mtrCDE |
β-lactams | wt | wt | wt |
| mtrRpro | A35del | A35del | wt | |
| macAB | macrolides | wt | wt | wt |
| macABpro | wt | wt | wt | |
| mefA | macrolides | wt | wt | wt |
| norM | fluoroquinolones | wt | wt | wt |
| norMpro | wt | wt | wt | |
Note: “-” – the gene was not found; “wt” – wild-type sequence.
Results of molecular mapping of N. gonorrhoeae
|
Genes and the encoded |
Sequence types and numbers of | ||
|---|---|---|---|
| 20/15/004 | 41/15/003 | 19/15/005 | |
| NG-MAST | 1407 | 12556 | 12450 |
| porB | 908 | 971 | 931 |
| tbpB | 110 | 6 | 2097 |
| MLST | 1901 | 1901 | 6721 |
| abcZ | 109 | 109 | 126 |
| adk | 39 | 39 | 39 |
| aroE | 170 | 170 | 67 |
| fumC | 111 | 111 | 111 |
| gdh | 148 | 148 | 146 |
| pdhC | 153 | 153 | 153 |
| pgm | 65 | 65 | 133 |